Cargando…
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897189/ https://www.ncbi.nlm.nih.gov/pubmed/33454844 http://dx.doi.org/10.1007/s10555-021-09955-5 |
_version_ | 1783653644357337088 |
---|---|
author | Tigyi, Gábor Dacheux, Mélanie A. Lin, Kuan-Hung Yue, Junming Norman, Derek Benyó, Zoltán Lee, Sue Chin |
author_facet | Tigyi, Gábor Dacheux, Mélanie A. Lin, Kuan-Hung Yue, Junming Norman, Derek Benyó, Zoltán Lee, Sue Chin |
author_sort | Tigyi, Gábor |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7897189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-78971892021-03-05 Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? Tigyi, Gábor Dacheux, Mélanie A. Lin, Kuan-Hung Yue, Junming Norman, Derek Benyó, Zoltán Lee, Sue Chin Cancer Metastasis Rev Commentary Springer US 2021-01-17 2021 /pmc/articles/PMC7897189/ /pubmed/33454844 http://dx.doi.org/10.1007/s10555-021-09955-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Commentary Tigyi, Gábor Dacheux, Mélanie A. Lin, Kuan-Hung Yue, Junming Norman, Derek Benyó, Zoltán Lee, Sue Chin Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title | Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title_full | Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title_fullStr | Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title_full_unstemmed | Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title_short | Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
title_sort | anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897189/ https://www.ncbi.nlm.nih.gov/pubmed/33454844 http://dx.doi.org/10.1007/s10555-021-09955-5 |
work_keys_str_mv | AT tigyigabor anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT dacheuxmelaniea anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT linkuanhung anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT yuejunming anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT normanderek anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT benyozoltan anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward AT leesuechin anticancerstrategiestargetingtheautotaxinlysophosphatidicacidreceptoraxisisthereapathforward |